Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia od Haider, S, McIntyre, A, van Stiphout, R, Winchester, L, Wigfield, S, Harris, A, Buffa, F

Radiogenomics monitoring in breast cancer identifies metabolism and immune checkpoints as early actionable mechanisms of resistance to anti-angiogenic treatment od Mehta, S, Hughes, N, Li, S, Jubb, A, Adams, R, Lord, S, Koumakis, L, van Stiphout, R, Padhani, A, Makris, A, Buffa, F, Harris, A

A semantic interoperability approach to support integration of gene expression and clinical data in breast cancer od Alonso-Calvo, R, Paraiso-Medina, S, Perez-Rey, D, Alonso-Oset, E, Van Stiphout, R, Yu, S, Taylor, M, Buffa, F, Fernandez-Lozano, C, Pazos, A, Maojo, V

Gemcitabine-induced TIMP1 attenuates therapy response and promotes tumor growth and liver metastasis in pancreatic cancer od D'Costa, Z, Jones, K, Azad, A, van Stiphout, R, Lim, S, Gomes, A, Kinchesh, P, Smart, S, McKenna, W, Buffa, F, Sansom, O, Muschel, R, O'Neill, E, Fokas, E